国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Human Speedy protein A (SPDYA) CSB-YP708792HU
CSB-EP708792HU
CSB-BP708792HU
CSB-MP708792HU
CSB-EP708792HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrolide export ATP-binding/permease protein MacB (macB), partial CSB-YP708793NFZ1
CSB-EP708793NFZ1
CSB-BP708793NFZ1
CSB-MP708793NFZ1
CSB-EP708793NFZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human coronavirus HKU1 Spike glycoprotein (S), partial CSB-YP708794HIU
CSB-BP708794HIU
CSB-MP708794HIU
CSB-EP708794HIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. DNA-directed RNA polymerase subunit gamma (rpoC1), partial CSB-YP708795FPZ
CSB-EP708795FPZ
CSB-BP708795FPZ
CSB-MP708795FPZ
CSB-EP708795FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Bicarbonate-binding protein CmpA (cmpA) CSB-YP708796FPZ
CSB-EP708796FPZ
CSB-BP708796FPZ
CSB-MP708796FPZ
CSB-EP708796FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem II D2 protein 2 (psbD2), partial CSB-YP708797FPZ1
CSB-EP708797FPZ1
CSB-BP708797FPZ1
CSB-MP708797FPZ1
CSB-EP708797FPZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. NAD (P)H-quinone oxidoreductase subunit H (ndhH) CSB-YP708798FPZ
CSB-EP708798FPZ
CSB-BP708798FPZ
CSB-MP708798FPZ
CSB-EP708798FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Type III pantothenate kinase (coaX) CSB-YP708799FPZ
CSB-EP708799FPZ
CSB-BP708799FPZ
CSB-MP708799FPZ
CSB-EP708799FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Cobyrinic acid A,C-diamide synthase (cobB) CSB-YP708800FPZ
CSB-EP708800FPZ
CSB-BP708800FPZ
CSB-MP708800FPZ
CSB-EP708800FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Magnesium-protoporphyrin IX monomethyl ester [oxidative] cyclase (acsF) CSB-YP708801FPZ
CSB-EP708801FPZ
CSB-BP708801FPZ
CSB-MP708801FPZ
CSB-EP708801FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Undecaprenyl-diphosphatase (uppP), partial CSB-YP708802FPZ1
CSB-EP708802FPZ1
CSB-BP708802FPZ1
CSB-MP708802FPZ1
CSB-EP708802FPZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Enolase-phosphatase E1 (mtnC) CSB-YP708803FPZ
CSB-EP708803FPZ
CSB-BP708803FPZ
CSB-MP708803FPZ
CSB-EP708803FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Glycine cleavage system H protein (gcvH) CSB-YP708804FPZ
CSB-EP708804FPZ
CSB-BP708804FPZ
CSB-MP708804FPZ
CSB-EP708804FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Chaperone protein DnaK 3 (dnaK3), partial CSB-YP708805FPZ
CSB-EP708805FPZ
CSB-BP708805FPZ
CSB-MP708805FPZ
CSB-EP708805FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. DNA replication and repair protein recF (recF) CSB-YP708806FPZ
CSB-EP708806FPZ
CSB-BP708806FPZ
CSB-MP708806FPZ
CSB-EP708806FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable inorganic polyphosphate/ATP-NAD kinase 1 (ppnK1) CSB-YP708807FPZ
CSB-EP708807FPZ
CSB-BP708807FPZ
CSB-MP708807FPZ
CSB-EP708807FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Adenylosuccinate synthetase (purA) CSB-YP708808FPZ
CSB-EP708808FPZ
CSB-BP708808FPZ
CSB-MP708808FPZ
CSB-EP708808FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP708809FPZ
CSB-EP708809FPZ
CSB-BP708809FPZ
CSB-MP708809FPZ
CSB-EP708809FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Phosphoadenosine phosphosulfate reductase (cysH) CSB-YP708810FPZ
CSB-EP708810FPZ
CSB-BP708810FPZ
CSB-MP708810FPZ
CSB-EP708810FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Elongation factor Ts (tsf) CSB-YP708811FPZ
CSB-EP708811FPZ
CSB-BP708811FPZ
CSB-MP708811FPZ
CSB-EP708811FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>